The international cannabis industry is shifting, with North America facing pricing and regulatory challenges while Europe, especially medical cannabis, becomes a key growth region. Tilray Brands is expanding in Germany, Italy, and the UK, operating GMP-certified facilities in Germany and Portugal. It focuses on production, research, and regulatory cooperation. Germany is its main European market, driving consolidation and increased competition across the region.